Search

  • HOME
  • Search
Original Articles
Diabetes, Obesity and Metabolism
2180
Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials
Shinje Moon, Jibeom Lee, Hye Soo Chung et al.
Endocrinol Metab. 2021;36(3):647-660.   Published online June 18, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Diabetes / Endocrine Research
2131
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng et al.
Endocrinol Metab. 2021;36(1):157-170.   Published online February 24, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Review Articles
Diabetes
2116
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Hun Jee Choe, Young Min Cho
Endocrinol Metab. 2021;36(1):22-29.   Published online February 24, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab. 2017;32(3):316-325.   Published online September 18, 2017
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
Obesity and Metabolism / Clinical Study
Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
Sang Ah Lee, Gwanpyo Koh, Suk Ju Cho, So-Yeon Yoo, Sang Ouk Chin
Endocrinol Metab. 2016;31(3):439-445.   Published online September 26, 2016
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Review Articles
Obesity and Metabolism
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab. 2016;31(2):258-274.   Published online April 25, 2016
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
Obesity and Metabolism / Clinical Study
Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus
Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim et al.
Endocrinol Metab. 2016;31(1):134-141.   Published online March 16, 2016
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Bone Metabolism
Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
Yun Kyung Jeon, Min Jung Bae, Ju In Kim et al.
Endocrinol Metab. 2014;29(4):567-573.   Published online December 29, 2014
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Obesity and Metabolism
A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth
Hee Young Kim, Jong-Ik Hwang, Mi Jin Moon, Jae Young Seong
Endocrinol Metab. 2014;29(3):320-327.   Published online September 25, 2014
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Review Articles
Obesity and Metabolism
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Young Min Cho, Rhonda D. Wideman, Timothy J. Kieffer
Endocrinol Metab. 2013;28(4):262-274.   Published online December 12, 2013
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    

Endocrinology
and Metabolism

Print ISSN: 2093-596X
Online ISSN: 2093-5978



Editorial Office
101-2503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-716-2428    Fax: +82-2-714-5103    E-mail: journal@endocrinology.or.kr                

Copyright © 2021 by Korean Endocrine Society.

Developed in M2PI

Close layer
prev next